首页> 外文期刊>Head and Neck Pathology >Update to the College of American Pathologists Reporting on Thyroid Carcinomas
【24h】

Update to the College of American Pathologists Reporting on Thyroid Carcinomas

机译:美国病理学家学院关于甲状腺癌的最新报道

获取原文
获取原文并翻译 | 示例
       

摘要

Background The reporting of thyroid carcinomas follows the recommendations of the College of American Pathologists (CAP) protocols and includes papillary carcinoma, follicular carcinoma, anaplastic carcinoma and medullary carcinoma. Despite past and recent efforts, there are a number of controversial issues in the classification and diagnosis of thyroid carcinomas (TC) that, potentially impact on therapy and prognosis of patients with TC. Discussion The most updated version of the CAP thyroid cancer protocol incorporates recent changes in histologic classification as well as changes in the staging of thyroid cancers as per the updated American Joint Commission on Cancer staging manual. Among the more contentious issues in the pathology of thyroid carcinoma include the defining criteria for tumor invasiveness. While there are defined criteria for invasion, there is not universal agreement in what constitutes capsular invasion, angioinvasion and extrathyroidal invasion. Irrespective of the discrepant views on invasion, pathologists should report on the presence and extent (focal, widely) of capsular invasion, angioinvasion and extrathyroidal extension. These findings assist clinicians in their assessment of the recurrence risk and potential for metastatic disease. It is beyond the scope of this paper to detail the entire CAP protocol for thyroid carcinomas; rather, this paper addresses some of the more problematic issues confronting pathologists in their assessment and reporting of thyroid carcinomas. Conclusion The new CAP protocol for reporting of thyroid carcinomas is a step toward improving the clinical value of the histopathologic reporting of TC. Large meticulous clinico-pathologic and molecular studies with long term follow up are still needed in order to increase the impact of microscopic examination on the prognosis and management of TC.
机译:背景技术甲状腺癌的报告遵循美国病理学家学院(CAP)方案的建议,包括乳头状癌,滤泡癌,间变性癌和髓样癌。尽管有过去和最近的努力,但是在甲状腺癌(TC)的分类和诊断中仍存在许多有争议的问题,这些问题可能会影响TC患者的治疗和预后。讨论根据最新的美国癌症联合委员会分期手册,CAP甲状腺癌协议的最新版本结合了组织学分类的最新变化以及甲状腺癌分期的变化。在甲状腺癌病理学中更具争议的问题包括确定肿瘤浸润性的标准。尽管有明确的浸润标准,但对于包膜浸润,血管浸润和甲状腺外浸润的构成还没有达成共识。不论对浸润的看法如何,病理学家均应报告囊膜浸润,血管浸润和甲状腺外扩张的存在和程度(局部,广泛)。这些发现有助于临床医生评估复发风险和转移性疾病的可能性。详细介绍甲状腺癌的整个CAP方案超出了本文的范围。相反,本文解决了病理学家在评估和报告甲状腺癌时面临的一些问题。结论用于甲状腺癌报告的新CAP方案是提高TC组织病理学报告临床价值的一步。为了增加显微检查对TC的预后和管理的影响,仍然需要长期的大量细致的临床病理和分子研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号